Production (Stage)
Zai Lab Limited
ZLAB
$31.32
-$1.18-3.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 106.49M | 109.07M | 102.27M | 100.50M | 87.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 106.49M | 109.07M | 102.27M | 100.50M | 87.15M |
| Cost of Revenue | 99.38M | 94.34M | 102.90M | -4.25M | 88.26M |
| Gross Profit | 7.11M | 14.73M | -634.00K | 104.75M | -1.12M |
| SG&A Expenses | 63.42M | 82.62M | 67.22M | 79.71M | 69.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 162.80M | 176.96M | 170.12M | 176.57M | 157.46M |
| Operating Income | -56.31M | -67.89M | -67.85M | -76.06M | -70.31M |
| Income Before Tax | -48.44M | -81.68M | -41.67M | -80.28M | -53.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.44M | -81.68M | -41.67M | -80.28M | -53.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.44M | -81.68M | -41.67M | -80.28M | -53.47M |
| EBIT | -56.31M | -67.89M | -67.85M | -76.06M | -70.31M |
| EBITDA | -52.85M | -64.86M | -64.98M | -73.12M | -67.30M |
| EPS Basic | -4.48 | -7.96 | -4.25 | -8.23 | -5.50 |
| Normalized Basic EPS | -0.27 | -0.50 | -0.26 | -0.45 | -0.37 |
| EPS Diluted | -4.48 | -7.96 | -4.25 | -8.23 | -5.50 |
| Normalized Diluted EPS | -0.27 | -0.50 | -0.26 | -0.45 | -0.37 |
| Average Basic Shares Outstanding | 108.08M | 102.68M | 98.17M | 97.59M | 97.31M |
| Average Diluted Shares Outstanding | 10.81M | 10.27M | 9.82M | 9.76M | 9.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |